Literature DB >> 11262457

Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus.

A Duerr1, B Kieke, D Warren, K Shah, R Burk, J F Peipert, P Schuman, R S Klein.   

Abstract

OBJECTIVE: Correlates of abnormal human immunodeficiency virus cervical cytologic findings were examined among women infected with human immunodeficiency virus and uninfected women. STUDY
DESIGN: We performed a cross-sectional analysis of baseline data on demographically similar women with infection or risk factors for it.
RESULTS: Among 1050 women without hysterectomy, squamous intraepithelial lesions were more common among women infected with human immunodeficiency virus than among uninfected women (18.8% vs 5.3%; P <.001). In multivariate analysis the association of squamous intraepithelial lesions with human papillomavirus infection was strong; adjusted prevalence ratios were 27 for high-risk, 25 for intermediate-risk, and 10 for low-risk types (95% confidence intervals, 12-58, 12-54, and 4-25, respectively). Much lower adjusted prevalence ratios were seen for the only other factor significantly associated with squamous intraepithelial lesions, namely, infection with human immunodeficiency virus in conjunction with a reduced CD4(+) cell count. Adjusted prevalence ratios were 1.9 for CD4(+) cell counts <200 and 1.6 for CD4(+) cell counts between 200 and 500 (95% confidence intervals, 1.2-3.0 and 1.0-2.5, respectively). Adjusted attributable fractions calculated for this study population indicated that if both human immunodeficiency virus and human papillomavirus were removed, 47.6% of the observed lesions with atypical squamous cells of uncertain significance and 93.4% of the observed squamous intraepithelial lesions would be prevented.
CONCLUSION: Squamous intraepithelial lesions are more common among human immunodeficiency virus-infected women and are associated most commonly with high- and intermediate-risk human papillomavirus types and secondarily with human immunodeficiency virus-associated immune compromise.

Entities:  

Mesh:

Year:  2001        PMID: 11262457     DOI: 10.1067/mob.2001.111791

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  15 in total

1.  Factors associated with time to colposcopy after abnormal Pap testing in HIV-infected women.

Authors:  Amy S Baranoski; Elizabeth A Stier
Journal:  J Womens Health (Larchmt)       Date:  2011-12-05       Impact factor: 2.681

Review 2.  Human papillomavirus in the HIV-infected host: epidemiology and pathogenesis in the antiretroviral era.

Authors:  Cristina Brickman; Joel M Palefsky
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

3.  Risk factors for nonadherence with Pap testing in HIV-infected women.

Authors:  Amy S Baranoski; C Robert Horsburgh; L Adrienne Cupples; Ann Aschengrau; Elizabeth A Stier
Journal:  J Womens Health (Larchmt)       Date:  2011-08-31       Impact factor: 2.681

4.  Study of Prevalence of Abnormal Pap Smear and its Associated Risk Factors in HIV Positive Women: A Cross-sectional Study.

Authors:  S Prathima; B Latha; T R Ashakiran
Journal:  J Obstet Gynaecol India       Date:  2021-08-09

Review 5.  Gynecologic issues in the HIV-infected woman.

Authors:  Helen E Cejtin
Journal:  Infect Dis Clin North Am       Date:  2008-12       Impact factor: 5.982

6.  Prevalence and correlates of genital warts in Kenyan female sex workers.

Authors:  Barbara E Kavanaugh; Katherine Odem-Davis; Walter Jaoko; Benson Estambale; James N Kiarie; Linnet N Masese; Ruth Deya; Lisa E Manhart; Susan M Graham; Raymond Scott McClelland
Journal:  Sex Transm Dis       Date:  2012-11       Impact factor: 2.830

7.  Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999.

Authors:  Dawn K Smith; Lytt I Gardner; Ruby Phelps; Merle E Hamburger; Charles Carpenter; Robert S Klein; Ann Rompalo; Paula Schuman; Scott D Holmberg
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

8.  Association between human papillomavirus and human T-lymphotropic virus in indigenous women from the Peruvian Amazon.

Authors:  Magaly M Blas; Isaac E Alva; Patricia J Garcia; Cesar Carcamo; Silvia M Montano; Ricardo Muñante; Joseph R Zunt
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

9.  Women's Health Care Utilization among Harder-to-Reach HIV-Infected Women ever on Antiretroviral Therapy in British Columbia.

Authors:  Xuetao Wang; Kate A Salters; Wen Zhang; Lawrence McCandless; Deborah Money; Neora Pick; Julio S G Montaner; Robert S Hogg; Angela Kaida
Journal:  AIDS Res Treat       Date:  2012-11-26

10.  Costs and Cost Effectiveness of Three Approaches for Cervical Cancer Screening among HIV-Positive Women in Johannesburg, South Africa.

Authors:  Naomi Lince-Deroche; Jane Phiri; Pam Michelow; Jennifer S Smith; Cindy Firnhaber
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.